ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Metsera Inc.
70.50
0.0000
成交量:
- -
成交額:
- -
市值:
74.29億
市盈率:
-11.96
高:
70.50
開:
70.50
低:
70.50
收:
70.50
52周最高:
83.86
52周最低:
12.30
股本:
1.05億
流通股本:
6,451.37萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-5.8924
每股收益(LYR):
-14.4907
淨資產收益率:
-134.66%
總資產收益率:
-38.77%
市淨率:
22.03
市盈率(LYR):
-4.87
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
背景資料-隨着競爭白熱化,減肥藥開發商排隊開發利潤豐厚的市場
路透中文
·
2025/12/12
背景資料-隨着競爭白熱化,減肥藥開發商排隊開發利潤豐厚的市場
路透中文
·
2025/12/08
背景資料-隨着競爭白熱化,減肥藥開發商排隊開發利潤豐厚的市場
路透中文
·
2025/11/25
若被「剔除」指數,這對「幣圈龍頭股」MTSR意味着什麼?
华尔街见闻
·
2025/11/22
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MTSR"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"MTSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":70.5,"timestamp":1770411600000,"preClose":70.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":64513712,"shares":105376189,"eps":-5.892395,"marketStatus":"休市中","change":0,"latestTime":"02-06 16:00:00 EST","open":70.5,"high":70.5,"low":70.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.892395,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":70.5,"volumeRatio":0,"impliedVol":0.3139,"impliedVolPercentile":0.2016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","floatShares":64513712,"roa":"-38.77%","roe":"-134.66%","lyrEps":-14.490661,"shares":105376189,"dividePrice":0,"high":70.5,"amplitude":0,"preClose":70.5,"low":70.5,"week52Low":12.3,"pbRate":"22.03","week52High":83.8599,"institutionHeld":0,"latestPrice":70.5,"eps":-5.892395,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.892395,"open":70.5,"prevYearClose":70.5,"prevWeekClose":70.5,"prevMonthClose":70.5,"prevQuarterClose":70.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTSR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"MTSR","reason":null,"defaultRemindTime":1763130600000,"announcedDate":"2025-11-12","type":"delisting","dateTimestamp":1763096400000},{"market":"US","date":"2025-11-12","symbol":"MTSR","fiscalQuarterEnding":"2025/09","expectedEps":-0.56,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.11},{"market":"US","date":"2025-07-28","symbol":"MTSR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1753675200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-12","symbol":"MTSR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-03-26","symbol":"MTSR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-3.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTSR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTSR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1761886800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTSR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTSR","date":"2025-11-14","current":-11.964575,"percent":0.036082,"low":-55.8522,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"high":-6.570442,"avg":-14.489177,"sd":5.001483,"marketCap":7429021324},"quantilePoints":[{"date":"2025-02-07","current":-17.973411,"twenty":-17.939327,"median":-17.8882,"eighty":-17.837073,"marketCap":3042628924},{"date":"2025-02-14","current":-18.277736,"twenty":-18.639274,"median":-18.277736,"eighty":-17.958804,"marketCap":3094146515},{"date":"2025-02-21","current":-19.257661,"twenty":-19.263748,"median":-18.612493,"eighty":-17.973411,"marketCap":3260033158},{"date":"2025-02-28","current":-15.222317,"twenty":-19.263748,"median":-18.292952,"eighty":-17.802989,"marketCap":2576909901},{"date":"2025-03-07","current":-16.749262,"twenty":-19.257661,"median":-17.973411,"eighty":-16.634383,"marketCap":2835398748},{"date":"2025-03-14","current":-15.094245,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":2555229332},{"date":"2025-03-21","current":-17.309229,"twenty":-18.72205,"median":-17.732316,"eighty":-15.847091,"marketCap":2930192911},{"date":"2025-03-28","current":-15.074845,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":3152557072},{"date":"2025-04-04","current":-10.624224,"twenty":-18.709149,"median":-17.433667,"eighty":-15.417782,"marketCap":2221812131},{"date":"2025-04-11","current":-6.570442,"twenty":-18.612493,"median":-16.926585,"eighty":-14.065167,"marketCap":1374056864},{"date":"2025-04-17","current":-8.815846,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"marketCap":1843631343},{"date":"2025-04-25","current":-10.639294,"twenty":-18.362232,"median":-16.039969,"eighty":-10.465489,"marketCap":2224963638},{"date":"2025-05-02","current":-11.734368,"twenty":-18.283822,"median":-15.629326,"eighty":-9.926993,"marketCap":2453973115},{"date":"2025-05-09","current":-12.437626,"twenty":-18.170614,"median":-15.417782,"eighty":-10.4896,"marketCap":2601043422},{"date":"2025-05-16","current":-10.120836,"twenty":-18.143134,"median":-15.084545,"eighty":-9.926993,"marketCap":2690472328},{"date":"2025-05-23","current":-11.083125,"twenty":-18.007321,"median":-13.673351,"eighty":-10.08689,"marketCap":2946282563},{"date":"2025-05-30","current":-10.903313,"twenty":-17.962456,"median":-12.437626,"eighty":-10.237022,"marketCap":2898482293},{"date":"2025-06-06","current":-11.330119,"twenty":-17.863854,"median":-12.078462,"eighty":-10.380871,"marketCap":3011942274},{"date":"2025-06-13","current":-13.665697,"twenty":-17.760585,"median":-12.111113,"eighty":-10.505751,"marketCap":3632820504},{"date":"2025-06-20","current":-10.950736,"twenty":-17.702451,"median":-12.009847,"eighty":-10.478878,"marketCap":2911088957},{"date":"2025-06-27","current":-11.345927,"twenty":-17.568059,"median":-11.719298,"eighty":-10.542899,"marketCap":3016144495},{"date":"2025-07-03","current":-11.638368,"twenty":-17.408779,"median":-11.681839,"eighty":-10.571353,"marketCap":3093885594},{"date":"2025-07-11","current":-14.388896,"twenty":-17.268165,"median":-11.697647,"eighty":-10.619566,"marketCap":3825072138},{"date":"2025-07-18","current":-17.506951,"twenty":-17.303722,"median":-11.789624,"eighty":-10.623027,"marketCap":4653960333},{"date":"2025-07-25","current":-15.67129,"twenty":-17.246135,"median":-12.009847,"eighty":-10.627238,"marketCap":4165977359},{"date":"2025-08-01","current":-11.259046,"twenty":-17.080186,"median":-12.060267,"eighty":-10.669177,"marketCap":3465782198},{"date":"2025-08-08","current":-10.542344,"twenty":-16.963959,"median":-11.907491,"eighty":-10.669177,"marketCap":3245165568},{"date":"2025-08-15","current":-10.340985,"twenty":-16.859629,"median":-11.799396,"eighty":-10.571353,"marketCap":3183182801},{"date":"2025-08-22","current":-11.194202,"twenty":-16.776854,"median":-11.704228,"eighty":-10.619566,"marketCap":3445821646},{"date":"2025-08-29","current":-11.958684,"twenty":-16.726286,"median":-11.700938,"eighty":-10.623027,"marketCap":3681146051},{"date":"2025-09-05","current":-12.385292,"twenty":-16.634383,"median":-11.74414,"eighty":-10.624224,"marketCap":3812465474},{"date":"2025-09-12","current":-12.712928,"twenty":-16.561345,"median":-11.903146,"eighty":-10.627666,"marketCap":3913318790},{"date":"2025-09-19","current":-12.252191,"twenty":-16.438168,"median":-11.874013,"eighty":-10.639294,"marketCap":3771493814},{"date":"2025-09-26","current":-17.959018,"twenty":-16.749262,"median":-11.907491,"eighty":-10.774419,"marketCap":5528180703},{"date":"2025-10-03","current":-17.681988,"twenty":-17.103908,"median":-11.968922,"eighty":-10.788708,"marketCap":5442905015},{"date":"2025-10-10","current":-17.989799,"twenty":-17.506951,"median":-12.044006,"eighty":-10.863794,"marketCap":5537655780},{"date":"2025-10-17","current":-18.078722,"twenty":-17.750391,"median":-12.092917,"eighty":-10.890458,"marketCap":5565028223},{"date":"2025-10-24","current":-18.000059,"twenty":-17.870095,"median":-12.173695,"eighty":-10.903313,"marketCap":5540814139},{"date":"2025-10-31","current":-21.796385,"twenty":-17.928237,"median":-12.282118,"eighty":-10.950736,"marketCap":6709406898},{"date":"2025-11-07","current":-27.891028,"twenty":-17.959018,"median":-12.385292,"eighty":-10.986017,"marketCap":8585472031},{"date":"2025-11-14","current":-24.134147,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"marketCap":7429021324}],"updateTime":1770442821232},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTSR\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590505938","title":"背景資料-隨着競爭白熱化,減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505938","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505938?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 20:04","pubTimestamp":1765541053,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化,减肥药开发商排队开发利润丰厚的市场修改日期线,在第 19、20、27、36 和 54 段增加新的细节。今年8月,该制药公司称其试验性减肥药orforglipron ,在一项晚期试验中,以36毫克的最高剂量服用72周,可帮助患有2型糖尿病的超重成年人减轻10.5%的体重。服用最高剂量Ozempic的糖尿病患者体重大约减轻了6%。礼来公司希望在今年年底前获得监管部门对orfglipron的批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4S3XI0UM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044865.SGD","LU2491050154.USD","02105","OPK","ALT","LU1989772923.USD","VKTX","LU2114397693.USD","MTSR","BK4588","LU1066051811.HKD","LU0208291251.USD","LU1551013425.SGD","LU0786609619.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU1084165304.USD","600196","LU0345777659.USD","LU0310800379.SGD","LU1116320901.HKD","SRRK","LU0203345920.USD","LU1037948897.HKD","LU1917777945.USD","LU2237443622.USD","LU0058720904.USD","BK0183","MRK","LU0784383803.USD","AZN.UK","03692","LU0969580561.USD","LU1894683348.USD","LU2023250504.SGD","SG9999014914.USD","LU0689472784.USD","LU1003076772.USD","PFE","03933","LLY","00656","GPCR","LU1929549753.HKD","LU1057294990.SGD","03165","LU0949170772.SGD","IE0002141913.USD","AMGN","LU0575583348.USD"],"gpt_icon":1},{"id":"2589535914","title":"背景資料-隨着競爭白熱化,減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2589535914","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589535914?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 22:29","pubTimestamp":1765204182,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化,减肥药开发商排队开发利润丰厚的市场更改日期线,重写标题,增加有关 Structure Therapeutics 公司最新数据的详细信息。诺和诺德计划在 2026 年第一季度将 CagriSema 提交监管部门审批。今年 9 月,MET-097i 在两项中期试验中显示,28 周后平均体重下降 14.1%。服用最高剂量Ozempic的糖尿病患者大约减轻了6%的体重。西兰制药 丹麦生物技术公司西兰制药ZELA.CO去年表示,在一项早期研究中,其减肥候选药物petrelintide的高剂量在每周服用16次后,体重平均减轻了8.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4T3XE15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","LU0823416689.USD","03165","LU0456855351.SGD","LU0786609619.USD","LU1104425308.USD","SG9999017495.SGD","IE0034235188.USD","03933","BK1583","IE0005OL40V9.USD","SG9999003800.SGD","LU2471134523.USD","02105","LU0943347566.SGD","LU1974910355.USD","BK4196","MTSR","MRK","LU2471134952.CNY","SG9999014559.SGD","SRRK","IE0002270589.USD","GPCR","LU0889565916.HKD","LU1037948897.HKD","LU0784385170.HKD","03692","LU2023251221.USD","LU0672654240.SGD","BK1191","VKTX","LU0238689110.USD","LU1261432733.SGD","LU0889565080.SGD","LU1232071149.USD","ALT","LU1496350502.SGD","LU2491050154.USD","SG9999018865.SGD","IE00BN8TJ469.HKD","LU0960981461.USD","LU1934455863.HKD","OPK","IE00B3T34201.USD","AZN.UK","LU1623119135.USD","AMGN"],"gpt_icon":1},{"id":"2586475794","title":"背景資料-隨着競爭白熱化,減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2586475794","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586475794?lang=zh_tw&edition=fundamental","pubTime":"2025-11-25 21:39","pubTimestamp":1764077953,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化,减肥药开发商排队开发利润丰厚的市场改写第1段,在第3段增加礼来估值里程碑,更新第9-0段诺和诺德试验细节。在其中一项试验中,该药帮助超重患者减轻了22.7%的体重,低于诺和诺德25%的预期。诺和诺德计划在 2026 年第一季度将 CagriSema 提交监管部门审批。今年 9 月,MET-097i 在两项中期试验中显示,28 周后平均体重下降 14.1%。服用最高剂量Ozempic的糖尿病患者体重大约减轻了6%。礼来公司希望在今年年底前获得监管部门对orfglipron的批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4S3X10WR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU0738911758.USD","LU0079474960.USD","SG9999015986.USD","BK4592","LU0949170772.SGD","03692","IE00B4R5TH58.HKD","LU0820561909.HKD","LU0557290698.USD","IE00BLSP4239.USD","LU2168564149.EUR","LU0353189680.USD","LU2063271972.USD","LU2168563687.JPY","SG9999015945.SGD","MRK","LU0198837287.USD","LU0553294199.USD","LLY","LU2746668461.USD","03933","LU0265550359.USD","AZN.UK","IE0004445239.USD","LU0109391861.USD","LU0823416689.USD","LU1023059063.AUD","LU1057294990.SGD","LU2168564065.EUR","SRRK","LU0094547139.USD","LU0225771236.USD","03165","GPCR","LU0964806797.USD","LU1551013342.USD","OPK","SG9999013999.USD","VKTX","LU2265009873.SGD","AMGN","SG9999014542.SGD","MTSR","SG9999011175.SGD","LU1069347547.HKD","LU1066051225.USD","ALT","02105"],"gpt_icon":1},{"id":"2585921120","title":"若被「剔除」指數,這對「幣圈龍頭股」MTSR意味着什麼?","url":"https://stock-news.laohu8.com/highlight/detail?id=2585921120","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585921120?lang=zh_tw&edition=fundamental","pubTime":"2025-11-22 11:26","pubTimestamp":1763781974,"startTime":"0","endTime":"0","summary":"指数提供商MSCI提议,可能将其全球可投资市场指数中的“数字资产财库公司”剔除,而MicroStrategy是此类公司的典型代表。据摩根大通分析,若被剔除,MicroStrategy的估值将面临“相当大的压力”,可能引发追踪MSCI指数的基金抛售约28亿美元的股票。过去一年,该公司股价已跌57%。","market":"sh","thumbnail":"https://static.tigerbbs.com/962be253ee7459c393769e9105cb1429","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/962be253ee7459c393769e9105cb1429"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3759918","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3759918","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR","BK4139"],"gpt_icon":1}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":198,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MTSR\",params:#limit:6,delay:false,,,undefined,":[]}}